Sublingual Buprenorphine for High-Risk Chronic Pain Patients

Drs. Wanhong Zheng & Patrick Marshalek from the West Virginia University High Risk Pain Clinic present their work and findings as published in their article “Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients”, J Clin Med. 2021 Mar: 10(5):973.

June 2023

You May Also Like

Related lectures

Psychadelics in HAPC

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

Perinatal and Pediatric PC

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

Non-Traditional HAPC Careers

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....